Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
Date:8/4/2008

Commitments and contingencies

Stockholders' equity:

Preferred stock $.001 par value; 2,000,000

shares authorized; none issued - -

Common stock $.001 par value, 200,000,000

shares authorized, 51,405,762 and 51,296,823

issued, respectively 51 51

Additional paid-in capital 229,855 229,056

Accumulated other comprehensive income 71 60

Accumulated deficit (99,042) (98,478)

Treasury stock, at cost, 15,207,435 and

6,824,192 shares (44,146) (22,443)

Total stockholders' equity 86,789 108,246

Total Liabilities and Stockholders' Equity $ 107,182 $ 128,441

Condensed Consolidated Statements Of Operations

(Unaudited)

(in thousands, except per share data)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Revenues

Maintenance and

services $10,552 $9,583 $20,305 $18,791

Software licenses and

system sales 3,023 2,919 6,058 6,144

Total revenues $13,575 $12,502 $26,363 $24,935

Costs and expenses

Cost of revenues:

Maintenance and

services (a) $4,692 $4,194 $8,961 $8,186

Software licenses and

system sales, including

amortization of software

costs of $571, $476,

$1,060 and $979,

respectively 1,731 1,
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Arcadia Radiology Medical Group Chooses AMICAS
2. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
3. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
4. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
5. eResearchTechnology Reports Second Quarter 2008 Results
6. SuperGen Reports 2008 Second Quarter Financial Results
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
9. CV Therapeutics Reports 2008 Second Quarter Financial Results
10. Gentiva Reports Strong Second Quarter led by Home Health Segment
11. United Therapeutics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... ... their 2015 bi-annual Pain Management Medical Advisory Board meeting in Palm Springs, California. ... Research and Development team to discuss new clinical practice and research ideas. The ...
(Date:7/6/2015)... Research and Markets ... the "Biotechnology for the Non-Biotechnologist" conference ... Non-Biotechnologist, ideal for non-Scientists and Scientists needing to ... of biotechnology. Ideal for Non-Scientists and ... techniques, and potential of biotechnology Why ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... For many ... a user had a high-end machine such as a Varian Cary 4000-7000, a Perkin ... widespread was this design that even NIST used them for their SRM-2031 series going ...
(Date:7/3/2015)... ... July 03, 2015 , ... The global failure analysis market is ... to 2020. The bioscience market is expected to grow at the highest CAGR of ... analysis equipment in the research labs and academic institutions for root cause analysis of ...
Breaking Biology Technology:Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... ... guilty man kills again. , ... Rochester, NY (PRWEB) May 5, 2010 -- National Association of Computer Voice Stress Analysts ... WHEC.com story concerns what can only be described as one of the worst ...
... the journal Cell that they have imaged a ... atoms, the first published instance of imaging biological complexes at ... by Hong Zhou, UCLA professor of microbiology, immunology and molecular ... angstroms. An angstrom is the smallest recognized division of a ...
... May 4 S*BIO Pte Ltd and Onyx Pharmaceuticals, Inc. ... and option and license commercialization agreement for S*BIO,s novel JAK2 inhibitors, SB1518 ... expanded agreement builds upon the development and commercialization collaboration between the two ... , , ...
Cached Biology Technology:NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 2NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 3NACVSA Points out Perils of Polygraph: Killer Passes Polygraph, Innocent Man Fails, Killer Goes On To Kill Again 4UCLA researchers use new microscope to 'see' atoms for first time 2UCLA researchers use new microscope to 'see' atoms for first time 3S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 2S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 3S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 4S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors 5
(Date:6/11/2015)... , June 11, 2015 Daon, a ... today that its IdentityX Mobile Authentication Platform v4.0 ... Online) Alliance is an industry consortium launched in ... for simpler, stronger authentication.  In order to receive ... a rigorous series of tests that measure compliance ...
(Date:6/9/2015)... MINNETONKA, Minn. , June 9, 2015   ... that supports the entire spectrum of clinical research, will ... eClinical technology platform at the 2015 Drug Information ... on June 15-17.  These presentations will include ... be rolled out in the upcoming iMedNet ...
(Date:6/8/2015)... , June 8, 2015  Trovagene, Inc. (NASDAQ: ... that clinical data featuring its Precision Cancer Monitoring SM ... and Liquid Biopsies conference in San Diego, CA ... AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy ... on June 13-16. "We continue to advance ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... Increasing the amount of vegetables in the first course of ... to eat more vegetables, according to Penn State nutrition researchers. ... strategically to encourage children and adults to eat more of ... calories," said Barbara J. Rolls, Helen A. Guthrie Chair of ...
... a potential new way of enabling patients with bacterial ... for this potentially blinding eye infection. The disease affects ... people in the United States. The study is in ... Howida Kamal Ibrahim and colleagues explain that bacterial ...
... , Menlo Park, Calif. The U.S. Department of ... of the Linac Coherent Light Source (LCLS), the world,s ... laser at the laboratory. The LCLS, which began operation ... laser light which are already providing new insights into ...
Cached Biology News:First course of veggies may appeal to hungry preschoolers 2First X-ray laser's early success brings approval for next-phase facility 2